Skip to content

Jobs updated Oct 23, 6:25 AM CT

COMPANY

Larkspur Biosciences

HQ: Cambridge, MA source · larkspur.bio ↗

Clinical Phase 2

Keywords: oncology

Location: Cambridge, MA · source · Oct 13, 2026

Profile checked Oct 10, 2026

1Trials (company is sponsor)

Timeline

Jul 7, 2026 Trial start Phase 1/Phase 2: A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors source ↗

Upcoming milestones

2029-06 (ESTIMATED) · Phase 1/Phase 2 · A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors · NCT07498725

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT07498725	A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors	Phase 1/Phase 2	Recruiting	Jul 7, 2026	2029-06 (estimated)